Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
08/2000
08/15/2000US6103877 Purified antibody which specifically binds to human hypermethylated in cancer-1 polypeptide of specific amino acid sequence or its immunoreactive fragments; for diagnosis/ prognosis of cell proliferative disorders such as cancer
08/15/2000US6103876 Isolated antibody that binds to human or bovine beta-migrating endothelial cell plasminogen activator inhibitor
08/15/2000US6103874 Human KDEL receptor
08/15/2000US6103869 Isolated polypeptide with a mutation at amino acid 464, 465, and/or 467 resulting in dominant negative inhibition of transforming growth factor-beta signaling; therapy and diagnosis of related diseases
08/15/2000US6103710 Glucocorticoid response elements
08/15/2000US6103525 For immunoaffinity purification of enzyme from human blood fractions
08/15/2000US6103521 Multispecific chimeric receptors
08/15/2000US6103513 Novel proteolytic enzyme; for the treatment of immune, proliferative and degratory defects
08/15/2000US6103507 Protein used to raise an immunological response against a bacteria; bactericides
08/15/2000US6103501 Recombinant protein which can be utilized as agonist or antagonist to its native cellular counterparts
08/15/2000US6103498 Mutant plasminogen activator-inhibitor type 1 (PAI-1) and uses thereof
08/15/2000US6103494 Nucleotide sequences which code protein associated with immmune response; for the detection of flea allergy dermatitis; for the detection of modulators of immune response
08/15/2000US6103485 Non-A non-B hepatitis related nucleic acids proteins peptides antigens and antibodies
08/15/2000US6103484 Method for immunodiagnosis of heartworm in mammals
08/15/2000US6103239 Modified HGP-30 heteroconjugates, compositions and methods of use
08/15/2000US6103238 Selectively deglycosylated human immunodeficiency virus type 1 envelope vaccines
08/15/2000US6103237 More stable to purification than wild type mature hk2 polypeptide.
08/15/2000US6103235 Exposing the recipient to an anti-cd3-dt immunotoxin with reduced anti-dt antibody binding so as to reduce the recipients t-cell lymphocyte population by at lest 80% in the presence or absence of anti-dt antibodies in the recipient
08/15/2000US6103234 Antibody to an inflammatory cytokine, said inflammatory cytokine comprising a mature macrophage inflammatory protein -2 (mmip-2)
08/15/2000US6103233 Cellular and serum protein anchors and conjugates
08/15/2000US6103232 Use of antibodies to the central nervous system myelin associated proteins; the monoclonal antibody in-1 and in-2 may be used to promote neurite outgrowth of nerve fibers over long distances in spinal cord lesions.
08/15/2000CA2196431C Icam-4 materials and methods
08/15/2000CA2142861C Novel uses of il-4 and/or il-10, and antibodies against the same
08/15/2000CA2046601C Production and use of anthelmintic agents and protective immunogens
08/15/2000CA2034484C Radioimmunotherapy using .alpha.-particles emission
08/11/2000CA2260376A1 New metalloproteases of the neprilysin family
08/10/2000WO2000046391A2 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof
08/10/2000WO2000046374A1 $i(candida albicans) srb-7
08/10/2000WO2000046251A2 Human polyclonal antibodies from transgenic nonhuman animals
08/10/2000WO2000046240A2 Polypeptides involved in immune response
08/10/2000WO2000046236A2 Novel rgs-containing molecules and uses thereof
08/10/2000WO2000045842A2 Methods for human allografting
08/10/2000WO2000045835A1 Vascular endothelial growth factor-2
08/10/2000WO2000034335A3 'death domain' containing receptors
08/10/2000WO2000032635A3 Tumor specific human monoclonal antibodies and methods of use
08/10/2000WO2000026251A3 A COMPLEX OF A CHAPERONE WITH ss-AMYLOID AND METHODS EMPLOYING THIS COMPLEX
08/10/2000WO2000026239A3 $i(chlamydia) antigens and corresponding dna fragments and uses thereof
08/10/2000WO2000024911A3 Human phospholipases
08/10/2000WO2000024773A3 Inhibition of transglutaminase-mediated microbial infection of a mammalian host
08/10/2000WO2000013706A8 Methods for detecting, preventing, and treating renal disorders by modulating, regulating, and inhibiting connective tissue growth factor
08/10/2000WO2000010599A8 IMMUNOGENIC β-PROPIONAMIDO-LINKED POLYSACCHARIDE PROTEIN CONJUGATE USEFUL AS A VACCINE PRODUCED USING AN N-ACRYLOYLATED POLYSACCHARIDE
08/10/2000WO2000010584A9 Method for detection of legionella bacteria employing purified antigen-specific antibodies
08/10/2000WO1999063936A9 Novel therapeutic agents that modulate endothelin receptors
08/10/2000DE19905048A1 Verwendung depletorisch oder mitogen wirkender Antikörper in der Immuntherapie Use depletorisch or mitogen-acting antibodies in immunotherapy
08/10/2000DE19905012A1 Arzneimittel enthaltend Anti-CD3- und Anti-Fcgamma-R-Antikörper zur begleitenden Behandlung bei Organtransplantationen Medicines containing anti-CD3 and anti-Fcgamma-R antibody for concomitant therapy in organ transplantation
08/10/2000DE19904795A1 Nucleic acid molecules for identifying particular bacteria, used to detect pathogens in foods, are specific for Bacillus cereus and B. thuringiensis
08/10/2000CA2492661A1 Non-stochastic generation of genetic vaccines and enzymes
08/10/2000CA2362239A1 Novel rgs-containing molecules and uses thereof
08/10/2000CA2362126A1 B7rp-1 polypeptides
08/10/2000CA2361615A1 The use of vascular endothelial growth factor 2 antagonist in the treatment of an injury to or disorder of an eye
08/10/2000CA2360834A1 Candida albicans srb-7
08/09/2000EP1026245A1 Antigen protein and nucleic acid coding for said protein
08/09/2000EP1026239A2 A new method for tapping the immunological repertoire
08/09/2000EP1026238A2 Cloned glutamic acid decarboxylase
08/09/2000EP1026237A2 Tau/neurofilament protein kinases pk40 & pk36
08/09/2000EP1026173A1 Antihuman thymidylate synthase monoclonal antibodies and hybridomas producing the same
08/09/2000EP1025856A2 Methods for modulating T Cell unresponsiveness
08/09/2000EP1025855A1 Medicament comprising anti-CD3 and anti-Fcy-R antibodies for the treatment following organ transplantation
08/09/2000EP1025854A1 Use in immunotherapy of antibody anti CD3/TCR acting as depleting or as mitogenic agent
08/09/2000EP1025853A2 Pharmaceutical composition containing S-nitroso-heme proteins and use thereof
08/09/2000EP1025246A1 Methods for identifying nucleic acid sequences and (poly)peptides which increase the expression yields of functional periplasmic proteins
08/09/2000EP1025238A2 Death associated kinase containing ankyrin repeats (dakar)
08/09/2000EP1025237A2 Human checkpoint kinase, hcds1, compositions and methods
08/09/2000EP1025236A2 Human checkpoint kinase, hcds1, compositions and methods
08/09/2000EP1025232A1 A novel mitogenic cyclin and uses thereof
08/09/2000EP1025230A2 ANTIBODIES, INCLUDING Fv MOLECULES, AND IMMUNOCONJUGATES HAVING HIGH BINDING AFFINITY FOR MESOTHELIN AND METHODS FOR THEIR USE
08/09/2000EP1025229A1 Chemokines with amino-terminal modifications
08/09/2000EP1025228A1 Human tumor necrosis factor receptor-like proteins tr11, tr11sv1, and tr11sv2
08/09/2000EP1025227A2 Human toll homologues
08/09/2000EP1025224A1 Human nip-45: interleukin-4 gene transcriptional trans-activator and its uses
08/09/2000EP1025223A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
08/09/2000EP1025220A1 JMY, A CO-ACTIVATOR FOR p300/CBP, NUCLEIC ACID ENCODING JMY AND USES THEREOF
08/09/2000EP1025218A1 Method to screen phage display libraries with different ligands
08/09/2000EP1025129A1 Monoclonal antibody to alpha2-macroglobulin and its use for detecting glucan
08/09/2000EP1025122A1 Fibroblast growth factor with hepatocyte proliferation activity
08/09/2000EP1025121A1 PEPTIDES CAPABLE OF INHIBITING THE INTERACTION BETWEEN PRESENILINS AND THE $g(b)-AMYLOID PEPTIDE OR ITS PRECURSOR
08/09/2000EP1024831A2 Application of tnf antagonists as medicaments for treating septic diseases
08/09/2000EP1024828A1 NOVEL pheS (BETA)
08/09/2000EP1024826A1 PASSIVE IMMUNIZATION AGAINST $i(CLOSTRIDIUM DIFFICILE) DISEASE
08/09/2000EP1024821A1 Novel prokaryotic polynucleotides, polypeptides and their uses
08/09/2000EP0640133B1 Recombinant dna molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections
08/09/2000EP0629238B1 Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy
08/09/2000EP0568645B1 Mixed specificity fusion proteins
08/09/2000EP0533846B1 The ciliary neurotrophic factor receptor
08/09/2000CN1262690A Ancrod specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of same
08/09/2000CN1262689A Isolated dendritic cell membrane protein genes
08/08/2000WO2001010911A2 Cell lines, ligands and antibody fragments for use in pharmaceutical compositions for preventing and treating haemostasis disorders
08/08/2000US6101449 Method for predicting the presence of congenital and therapeutic conditions from coagulation screening assays
08/08/2000US6100443 Universal donor cells
08/08/2000US6100390 Nucleotide sequences coding nematode protein; for the prevention of nematode infection of animals
08/08/2000US6100387 Chimeric polypeptides containing chemokine domains
08/08/2000US6100384 Antibodies immunologically specific for a signal mediator protein that induces cellular morphological alterations
08/08/2000US6100383 Fusion proteins comprising ICAM-R polypeptides and immunoglobulin constant regions
08/08/2000US6100379 Artificial generated amino acid sequences; for the development of diagnostic tools for the detection of connective tissue degradation by-products
08/08/2000US6100296 Modulation of inflammation related to columnar epithelia
08/08/2000US6100241 Nucleic acids encoding an immunogenic fragment of eimeria lactate dehydrogenase (ldh) which will react with antiserum raised against the ldh; preparing a vector vaccine against coccidiosis; administering to prevent coccidiosis in birds
08/08/2000US6100235 Methods of treating immune and inflammatory response with IL-17 receptors
08/08/2000US6100076 Amino acid sequence of enzyme which glycosylates an epidermal growth factor domain of a polypeptide with an activated fucose moiety
08/08/2000US6100071 Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production
08/08/2000US6100067 Molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a protein produced by P. falciparum at the sporozoite stage and in the hepatocytes